Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masako Mishima

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gastroenterology|October 9, 2018
Acute Respiratory Failure During Systemic ChemotherapyMasako Mishima, Takahiro Horimatsu, Shin'ichi Miyamoto
Gastroenterology|September 8, 2017
An Unusual Cause of Hepatic DysfunctionYuji Eso, Masako Mishima, Akihisa Fukuda
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 13, 2018
Intramucosal Metastasis of Gastric Cancer to the DuodenumMasako Mishima, Takaki Sakurai, Shin'ichi Miyamoto
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 5, 2014
Late-onset acetaminophen-induced allergic hepatitis with progression to chronicityMasako Mishima-Iwai, Ken Takahashi, Masataka Yokode, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 7, 2020
Branched-chain amino acid to tyrosine ratio is an essential pre-treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Clinical Journal of Gastroenterology|November 2, 2020
Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosisKentaro Iwaki, Yoshihide Ueda, Masako Mishima, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2021
A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubblesYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 31, 2021
Mac-2 binding protein glycosylation isomer predicts tolerability and clinical outcome of lenvatinib therapy for hepatocellular carcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Scientific Reports|June 2, 2026
True reactivation versus transient viremia: a retrospective analysis of HBV reactivation in resolved infectionTadashi Inuzuka, Atsushi Takai, Masayuki Ueno, et al.
Cancers|December 28, 2019
Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular CarcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gastroenterology|October 9, 2018
Acute Respiratory Failure During Systemic ChemotherapyMasako Mishima, Takahiro Horimatsu, Shin'ichi Miyamoto
Gastroenterology|September 8, 2017
An Unusual Cause of Hepatic DysfunctionYuji Eso, Masako Mishima, Akihisa Fukuda
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 13, 2018
Intramucosal Metastasis of Gastric Cancer to the DuodenumMasako Mishima, Takaki Sakurai, Shin'ichi Miyamoto
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 5, 2014
Late-onset acetaminophen-induced allergic hepatitis with progression to chronicityMasako Mishima-Iwai, Ken Takahashi, Masataka Yokode, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 7, 2020
Branched-chain amino acid to tyrosine ratio is an essential pre-treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Clinical Journal of Gastroenterology|November 2, 2020
Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosisKentaro Iwaki, Yoshihide Ueda, Masako Mishima, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2021
A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubblesYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 31, 2021
Mac-2 binding protein glycosylation isomer predicts tolerability and clinical outcome of lenvatinib therapy for hepatocellular carcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Scientific Reports|June 2, 2026
True reactivation versus transient viremia: a retrospective analysis of HBV reactivation in resolved infectionTadashi Inuzuka, Atsushi Takai, Masayuki Ueno, et al.
Cancers|December 28, 2019
Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular CarcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Pageof 2